INTRODUCTION
The guideline group was selected to be representative of UK based medi cal experts and patients. MEDLINE and EMBASE were searched system atically for publications in English from 1950-2006 using the key words: den tal, surgery, oral and anticoagulants. The writing group produced the draft guidelines, which were subsequently revised by consensus by members of the Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. The guidelines were then reviewed by a sounding board of approximately 100 UK haematolo gists, the BCSH (British Committee for Standards in Haematology), the British Society for Haematology Committee, the British Dental Association (BDA), and the National Patient Safety Agency (NPSA) and comments incorporated where appropriate. Criteria used to quote levels and grades of evidence are as out lined in appendix 3 of the Procedure for Guidelines Commissioned by the BCSH (http://www.bcshguidelines.com/ process1.asp#App3). 
SUMMARY OF KEY RECOMMENDATIONS

The risk of bleeding in anticoagulated patients undergoing oral surgery
Dental surgery in anticoagulated patients is common and historically their management has been controver sial following early reports of major bleeding in such individuals. 1 Many of the early reports of haemorrhage associated with dental surgery during this period predated the standardisation of oral anticoagulant control by means of the INR. In 1954, the American Heart Association recommended a therapeu tic range for oral anticoagulant ther apy of a prothrombin time ratio (PTR) of 2-2.5 using human brain reagents. 2 Later, the use of less sensitive commer cial thromboplastins was not accom panied by a change in the target PTR ratio. Clinicians, therefore, admin istered larger doses of oral antico agulants to achieve the target ratio, resulting in an increased incidence of haemorrhage. The development and introduction of the INR did not take place until 1983. 3 The risks of bleeding associated with dental extraction in individuals not receiving oral anticoagulants is approx imately 1%. 4, 5 In a review of ten studies of patients undergoing dental surgery and in whom oral anticoagulants were continued, 9% (89/990) had delayed postoperative bleeding and in 3.5% of cases this was classified as 'serious' ie not controlled by local measures. 4 Other studies have reported the incidence of minor bleeding as higher and in some cases up to 50%. 5 However, the inter pretation and comparison of bleeding rates in patients undergoing oral sur gery is difficult as rates for different procedures are not analysed separately, the definitions used to describe serious bleeding vary and surgery can involve the use of differing treatments to secure haemostasis. Surgical dentists in the primary care setting often have the skills to undertake any of the procedures listed above in the context of the anticoagulated patient. The skill and experience of the primary care dentist, together with the diffi culty of the procedure all need consideration.
What constitutes dental treatment?
Is it safe to discontinue anticoagulants prior to dental surgery?
The risk of thrombosis if anticoagulants are discontinued
The risk of thrombosis associated with temporarily discontinuing anticoagu lants prior to dental surgery is small but potentially fatal. In the review of Wahl, 5/493 (1%) patients undergoing 542 den tal procedures and in whom anticoagu lants were withdrawn specifi cally for surgery, had serious embolic complica tions of which four were fatal. 6 The four deaths comprised: a fatal cerebral embo lism 17 days after discontinuing war farin; one fatal myocardial infarction 19 days after interruption of therapy for nine days; one fatal cerebral throm boembolism fi ve days postoperatively and one patient died from a thromboem bolism but no other data are available.
The risk of major bleeding in patients undergoing oral surgery if anticoagulants are continued
Wahl reviewed 26 papers comprising 2,014 dental surgical procedures in 774 patients receiving continuous warfa rin therapy, including 1,694 patients undergoing single, multiple extrac tions and full mouth extractions. 6 This metanalysis included patients with an INR up to 4.0. Although some patients had minor oozing treated with local measures, more that 98% of patients receiving continuous anticoagulants had no serious bleeding problems. Many of the procedures were performed in patients with an INR above the present recom mended therapeutic levels of antico agulation. Twelve patients (<2%) had postoperative bleeding problems that were not controlled by local measures. Eight of these 12 episodes were associ ated with a supratherapeutic INR at the time of the procedure or in the week after. Major bleeding was rare (4/2012, 0.2%) for patients with a therapeutic INR (<4) undergoing dental surgery. There were no deaths.
Five randomised studies have been published since this systematic review. Devani et al. 7 randomised 65 patients on continuous warfarin therapy and under going 133 dental extractions to either stop warfarin two to three days prior to surgery (32 patients) resulting in a reduction in mean INR from 2.6 to 1.6, or to continue anticoagulants with no dose alteration (32 patients) and a mean pre-operative INR of 2.7 (range 2.2-3.9). All patients received local measures ('Surgicel' packing and sutures) to con trol post-operative bleeding. None of the patients had any immediate postopera tive bleeding and only one patient from each group had mild delayed haem orrhage, which was controlled with local measures.
Campbell et al. randomised 25 patients to either discontinue warfarin 72-96 hours prior to surgery (13 patients: mean INR 2.0: range 1.2-2.9) or to con tinue anticoagulants (12 patients: mean INR 2.0: range 1.1-3.0). 8 A further group of ten individuals not receiving antico agulants served to establish a baseline bleeding risk. No patient in any group had postoperative bleeding `suffi ciently severe to require therapeutic interven tion and there were no signifi cant dif ferences in blood loss between the three groups.
Evans randomised 109 patients on continuous oral anticoagulants requir ing dental extractions to either con tinue warfarin (57 patients) although if the INR was >4 on the day of surgery, the patient was withdrawn. 9 The control group (52 patients) stopped taking war farin two days prior to surgery and if the INR was >2 on the day of the pro cedure this was subsequently rebooked for the following day. Tranexamic acid mouthwashes were not allowed. The mean INR for the group taking anticoag ulants at the time of dental surgery was 2.5 (range 1.2-4.7) and for the group that discontinued anticoagulants 1.6 (range 1.2-2.3). The rate of bleeding was higher in the group continuing anticoagula tion (15/57, 26%) than in the control group (7/52, 14%) but the difference was not signifi cant.
Sacco et al. 10 randomised 131 patients on anticoagulants requiring dental sur gery -primarily dental extractions -to either reduce their warfarin dose 72 hours prior to surgery to achieve an INR of 1.5-2 on the day of surgery, or to continue anticoagulants with no altera tion, but this latter group received hae mostatic agents at the time of surgery and tranexamic acid mouthwashes for the following six days. Bleeding suf ficient to warrant additional haemo static measures was observed in 15% of the first group (mean INR 1.77 ± 0.26) and 9% of the second group (mean INR 2.89 ± 0.42).
Al-Mubarak et al. randomised 168 patients on warfarin undergoing den tal surgery to one of four groups: no socket suturing with or without discon tinuation of warfarin and socket sutur ing with or without discontinuation of warfarin (groups 1-4 respectively). 5 The percentage of patients who bled follow ing surgery was 12% in the group whose warfarin was stopped and who in addi tion had suturing of the socket (mean pre-operative INR of 1.79) compared to 36% in Group 4 with a mean pre-opera tive INR of 2.6 but whose warfarin was continued and who did not receive sutur ing of the sockets following extraction. However, this difference in bleeding was not clinically significant and no surgical intervention was necessary.
Recommendations: The risk of signifi cant bleeding in patients on oral anti coagulants and with a stable INR in the therapeutic range 2-4 is low. The risk of thrombosis if anticoagulants are discon tinued may be increased. Oral antico agulants should not be discontinued in the majority of patients requiring out patient dental treatment. An apprecia tion of the surgical skills of primary care dentists and the difficulty of surgery, particularly when INR levels approach 4, is also important when assessing the risk of bleeding. Individuals in whom the INR is unstable should be discussed with their anticoagulant management team (grade A level Ib).
Anticoagulants and prophylactic antibiotics
Patients undergoing dental surgery may be prescribed antibiotics to prevent endocarditis. Antibiotics prescribed commonly include amoxicillin, ampicil lin, clindamycin and azithromycin. 11 A single dose of an antibiotic is unlikely to have any significant effect upon the INR. Individuals who are prescribed more than a single dose of antibiotics should have the INR measured two to three days after starting treatment.
Recommendations: For patients stably anticoagulated on warfarin (INR 2-4) and who are prescribed a single dose of antibiotics as prophylaxis against endo carditis, there is no necessity to alter their anticoagulants (grade C, level IV).
Local haemostatic measures
Tranexamic acid binds to plasminogen and inhibits subsequent lysis of fi brin. Orally administered tranexamic acid does not appear in saliva at detectable levels 12 but as a mouthwash, the con centration of tranexamic acid remains sufficiently high to inhibit fi brinolysis for hours but insignificant levels are detected in the plasma.
In the UK, tranexamic acid mouth washes are not readily available in the primary care setting and dentists can not currently prescribe them. Four studies have evaluated the role of alter native treatments in patients undergoing dental extractions to secure haemos tasis. However, in two of these stud ies tranexamic acid was also used to secure haemostasis.
Blinder et al. 13 in a study of 150 patients undergoing dental extractions and without interruption of their anti coagulants, randomised patients to one of three groups: group 1 (50 patients mean INR 2.38) who were treated with gelatin sponges and sutures; group 2 (50 patients mean INR 2.7) who were treated with gelatin sponges, sutures and tranexamic acid mouthwashes and group 3 (50 patients mean INR 2.19) who received fibrin glue, gelatin sponges and sutures. Thirteen patients (8.6%) devel oped post-operative bleeding: three in group 1, six in group 2 and four in group 3. The use of gelatin sponges and sutures provided adequate haemostasis for dental extraction without interrup tion of anticoagulants. Tranexamic acid mouthwashes or fibrin glue offered no benefit over resorbable gelatin sponges plus suturing.
In a subsequent study of 249 patients undergoing 543 dental extractions with out interruption of their anticoagulant therapy 14 patients were divided into five groups according to their INR at the time of surgery. Local haemostasis in all groups was achieved with gelatin sponges and silk sutures. Overall, 12% developed post-operative bleeding but the incidence of bleeding was not sig nificantly different between group I (59 patients: mean INR 1.74) and group V (23 patients: mean INR 3.8).
In a study of 26 patients undergoing dental extraction with an INR of 2.0-4.2, the sockets were packed with a resorb able oxycellulose dressing ('Surgicel') and sutured with a resorbable suture. 20 A second group of patients (INR 2.1 4.1) received local packing of the sock ets with a fi brin adhesive ('Beriplast'). Only one patient in the second group had signifi cant postoperative haemor rhage. The authors concluded that fi brin adhesive is as effective as oxycellulose dressing in preventing post-extrac tion haemorrhage in patients receiving oral anticoagulants.
In a Spanish study of 150 patients on oral anticoagulants undergoing den tal extraction (229 sessions/367 dental extractions) and with an INR of 2-3 (145 cases 2-2.5; 84 cases 84 2.5-3) haemosta sis was secured using haemostatic gauze and/or sutures or a local compression. 15 In over 99% of cases the use of resorb able gelatin sponges plus sutures at the time of dental surgery was suffi cient to achieve haemostasis and only one case of severe bleeding was observed. How ever, all patients received tranexamic acid mouthwashes every six hours for two days.
In 2003 Zanon and colleagues 16 reported the results of a prospective study of 250 anticoagulated patients with INR values between 1.8-5.0 and 265 patients who were not receiving anticoagulation undergoing dental sur gery. In all groups receiving oral antico agulants, local haemostasis was secured with oxidised cellulose and silk sutures plus local application of a tranexamic acid saturated gauze swab for 30-60 minutes following surgery. There was no difference in bleeding complica tions between the two groups (4/250 for the anticoagulated group and 3/250 in the control group). When the anticoagulated group was strati fied according to INR (1.8-2, 2-3 and 3-4) bleeding complications were seen in 1.2%, 1.3% and 4.8% of patients respectively but this difference was not signifi cantly different. Five randomised trials have evaluated the role of tranexamic acid or other local haemostatic measures in patients under going oral surgery on continuous anti coagulant therapy.
In a study of 39 patients receiving oral anticoagulants for a cardiac valvular ste nosis, a prosthetic heart valve or a vas cular prosthesis, surgery was performed without a change in anticoagulation, but before suturing the operative fi eld was irrigated in 19 patients with 10 ml of a 4.8% solution of tranexamic acid and in 20 patients with placebo. 17 Patients were instructed to rinse their mouths with 10ml of placebo or tranexamic acid for two minutes, four times a day for 7 days. The range of INRs was estimated at between 2.5-4.8. There was a statisti cally significant difference between the two groups with 8/20 (40%) patients in the placebo group having a total of 10 postoperative bleeds compared to only 1/19 (5%) patients in the tranexamic acid-treated group.
In a second study, 93 patients under going invasive dental surgery were randomised to either tranexamic acid mouthwashes (4.8% four times a day for seven days) (44 patients) or placebo (45 patients). 18 Anticoagulants in this study were assessed by measuring plasma factor X levels and there were no dif ferences in factor X levels between the two groups of patients. In the group that received placebo mouthwashes, ten patients (22%) had bleeding problems requiring treatment but none in the tranexamic acid group, a difference that was statistically signifi cant.
A further study randomised 49 patients (undergoing 152 dental extractions) to either tranexamic acid (4.8% four times a day for seven days) (26 patients: mean INR 3.0 range 2.3-4.0) or autologous fibrin glue (23 patients: mean INR 3.1 range 2.1-4.0). 19 Two cases of post-oper ative bleeding were noted in the group that received autologous fibrin glue but both cases had elevated INRs (5.9/7.9) at the time of surgery. Tranexamic acid was found to be a more cost-effective alternative.
In a study of 85 patients on warfarin undergoing dental surgery randomised to tranexamic acid mouthwashes (two minutes four times a day: mean INR 2.7) for either two days or fi ve days (mean INR 2.8). 19 There were no signifi cant differences in bleeding complications between the two groups.
Sacco et al. reported a signifi cant difference in bleeding complications between a group of patients whose war farin dose was reduced 72 hours prior to surgery compared to those whose war farin continued uninterrupted but who received tranexamic acid mouthwashes for six days. The rate of bleeding was 15% in the first group compared to 9% in the second group.
The current ACCP guidelines rec ommend the use of tranexamic acid mouthwashes (or epsilon amino cap roic acid (EACA) mouthwashes) without interruption of anticoagulant therapy in anticoagulated patients undergoing dental surgery. Intravenous conscious sedation in children for outpatient dentistry (BDJ 2007; 203: [323] [324] [325] [326] [327] [328] [329] [330] [331] It has been brought to our attention that Table 4 in the above paper by Mikhael, Wray and Robb was printed incorrectly. The correct version of the table is given below. We wish to apologise to the authors and to readers for this error and any confusion and inconvenience that may have been caused. 
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